Hemochromatosis mutations in the general population: iron overload progression rate

被引:142
作者
Andersen, RV
Tybjaerg-Hansen, A
Appleyard, M
Birgens, H
Nordestgaard, BG
机构
[1] Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark
[2] Herlev Univ Hosp, Dept Hematol, DK-2730 Herlev, Denmark
[3] Univ Copenhagen Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark
[4] Univ Copenhagen, Bispebjerg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark
关键词
D O I
10.1182/blood-2003-10-3564
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The progression rate of iron overload in hereditary hemochromatosis in individuals in the general population is unknown. We therefore examined in the general population iron overload progression rate in C282Y homozygotes. Using a cohort study of the Danish general population, The Copenhagen City Heart Study, we genotyped 9174 individuals. The 23 C282Y homozygotes identified were matched to 2 subjects each of 5 other HFE genotypes with respect to sex, age, and alcohol consumption. As a function of biologic age, transferrin saturation increased from 50% to 70% from 25 to 85 years of age and from 70% to 80% from 35 to 80 years of age in female and male C282Y homozygotes, respectively. Equivalently, ferritin levels increased from 100 to 500 mug/L and decreased from 800 to 400 mug/L in female and male C282Y homozygotes. As a function of 25 years follow-up irrespective of age, transferrin saturation and ferritin levels increased slightly in male and female C282Y homozygotes. None of the C282Y homozygotes developed clinically overt hemochromatosis. In conclusion, individuals in the general population with C282Y homozygosity at most demonstrate modest increases in transferrin saturation and ferritin levels, and clinically overt hemochromatosis is rare. Therefore, C282Y homozygotes identified during population screening, and not because of clinically overt hemochromatosis, at most need to be screened for manifestations of hemochromatosis every 10 to 20 years. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:2914 / 2919
页数:6
相关论文
共 27 条
  • [1] Population screening for hemochromatosis
    Adams, PC
    [J]. HEPATOLOGY, 1999, 29 (04) : 1324 - 1327
  • [2] Åsberg A, 2001, SCAND J GASTROENTERO, V36, P1108
  • [3] Persons with screening-detected haemochromatosis:: as healthy as the general population?
    Åsberg, A
    Hveem, K
    Krüger, O
    Bjerve, KS
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (06) : 719 - 724
  • [4] Hemochromatosis: The genetic disorder of the twenty-first century
    Barton, JC
    Bertoli, LF
    [J]. NATURE MEDICINE, 1996, 2 (04) : 394 - 395
  • [5] BASSETT ML, 1984, GASTROENTEROLOGY, V87, P628
  • [6] SERUM FERRITIN AS A POSSIBLE MARKER OF THE HEMOCHROMATOSIS ALLELE
    BEAUMONT, C
    SIMON, M
    FAUCHET, R
    HESPEL, JP
    BRISSOT, P
    GENETET, B
    BOUREL, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (04) : 169 - 174
  • [7] Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
    Beutler, E
    Felitti, VJ
    Koziol, JA
    Ho, NJ
    Gelbart, T
    [J]. LANCET, 2002, 359 (9302) : 211 - 218
  • [8] The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic
    Beutler, E
    Felitti, V
    Gelbart, T
    Ho, N
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (05) : 329 - 337
  • [9] BEUTLERE, 2001, METABOLIC MOL BASES, P3127
  • [10] Bothwell TH, 1998, SEMIN HEMATOL, V35, P55